Schedule Dispatches
Schedule dispatches give a summary of changes coming out in the next month.
This is an early notification of the changes to be announced in the Update to the Pharmaceutical Schedule.
The full Update is available as a PDF(external link)
The changes will be published in the online Schedule around the 23rd of this month and are effective from next month.
For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz
17 July 2025 | August 2025 Pharmaceutical Schedule Dispatch
New Listings
- Daunorubicin inj 18.7 mg vial (Pfizer) (p’code 2710986) and inj 18.7 mg for ECP, 18.7 mg OP (Baxter) (p’code 2710978) – PCT only-Specialist
- Hydrogen peroxide (Crystaderm) crm 1%, 15 g OP (p’code 2703777)
- Irinotecan hydrochloride (Accord) inj 20 mg per ml, 25 ml vial – PCT only – Specialist, section 29 (p’code 2711036)
- Lenalidomide (Viatris) (Lenalidomide Viatris) cap 10 mg – Special Authority-Retail Pharmacy (p’code 2707535)
- Macrogol 3350 with potassium chloride, sodium bicarbonate and sodium chloride (Movicol) powder for oral soln 13.125 g with potassium chloride 46.6 mg, sodium bicarbonate 178.5 mg and sodium chloride 350.7 mg (p’code 2194864)
- Pegylated interferon alfa-2a (Pegasys (S29)) inj 135 mcg prefilled syringe – Special Authority – Retail pharmacy, section 29 and wastage claimable (p’code 2710994)
- Praziquantel (Distoside) tab 600 mg – section 29 and wastage claimable (p’code 2710684)
- Primaquine (Bayshore) tab 15 mg – Special Authority – Retail pharmacy, section 29 and wastage claimable (p’code 2664062)
- Salbutamol (UK Cipla) nebuliser soln, 1 mg per ml, 2.5 ml ampoule – up to 30 neb available on a PSO, section 29 and wastage claimable (p’code 2710811)
- Water (Fresenius Kabi) inj 10 ml ampoule – subsidy restrictions apply and up to 5 inj on a PSO (p’code 2565684)
Changes to restrictions, chemical names and presentations
- Albendazole (Eskazole) tab 400 mg – amended Special Authority criteria
- Budesonide with eformoterol – addition of stat dispensing and PSO quantities
- powder for inhalation 160 mcg with 4.5 mcg eformoterol fumarate per dose (equivalent to 200 mcg budesonide with 6 mcg eformoterol fumarate metered dose) (DuoResp Spiromax),
- aerosol inhaler 100 mcg with eformoterol fumarate 6 mcg (Vannair),
- powder for inhalation 100 mcg with eformoterol fumarate 6 mcg (Symbicort Turbuhaler 100/6),
- aerosol inhaler 200 mcg with eformoterol fumarate 6 mcg (Vannair)
- powder for inhalation 200 mcg with eformoterol fumarate 6 mcg (Symbicort Turbuhaler 200/6)
- Dulaglutide (Trulicity) inj 1.5 mg per 0.5 ml prefilled pen – amended Special Authority criteria
- Etoposide (Vepesid) cap 50 mg and 100 mg – addition of wastage claimable
- Hydroxychloroquine sulphate (Ipca-Hydroxychloroquine) tab 200 mg – removal of brand switch fee payable
- Ispaghula (Psyllium) husk (Konsyl-D) powder for oral soln, 500 g OP – PSS date amended
- Ivermectin (Stromectol) tab 3 mg – amended Special Authority criteria
- Levonorgestrel (Jadelle) subdermal implant (2 × 75 mg rods) – amended PSO quantity
- Levonorgestrel intra-uterine device 52 mg (Mirena) and intra-uterine device 13.5 mg (Jaydess) – addition of PSO quantity
- Liraglutide (Victoza) inj 6 mg per ml, 3 ml prefilled pen – amended Special Authority criteria
- Macrogol 3350 with potassium chloride, sodium bicarbonate and sodium chloride (Molaxole) powder for oral soln 13.125 g with potassium chloride 46.6 mg, sodium bicarbonate 178.5 mg and sodium chloride 350.7 mg – PSS date amended
- Pazopanib (Pazopanib Teva) tab 200 mg and 400 mg – removal of brand switch fee payable
- Sodium fusidate [fusidic acid] (Fucithalmic (ON)) eye drops 1%, 5 g OP – amended brand name
- Tetracycline (Accord) tab 250 mg – amended Special Authority criteria
- Tretinoin (Vesanoid) cap 10 mg – addition of wastage claimable
- Valganciclovir (Valganciclovir Viatris) tab 450 mg – amended Special Authority criteria
Increased subsidy
Chemical |
Presentation |
Fully subsidised brands |
---|---|---|
Azithromycin |
Tab 500 mg |
Zithromax |
Ispaghula (Psyllium) husk |
Powder for oral soln, 500 g OP |
Konsyl-D |
Macrogol 3350 with potassium chloride, sodium bicarbonate and sodium chloride |
Powder for oral soln 13.125 g with potassium chloride 46.6 mg, sodium bicarbonate 178.5 mg and sodium chloride 350.7 mg |
Molaxole |
Sodium acid phosphate |
Enema 16% with sodium phosphate 8% |
Fleet Phosphate Enema |
Decreased subsidy
Chemical |
Presentation |
Fully subsidised brands |
---|---|---|
Mirtazapine |
Tab 30 mg & 45 mg |
Noumed |